Fletikumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Fletikumab
Monoclonal antibody
Type?
TargetIL20
Clinical data
Other namesNNC0109-0012
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
ChEMBL
Chemical and physical data
FormulaC6494H10000N1728O2050S44
Molar mass146.5 kg/mol g·mol−1

Fletikumab (NNC0109-0012) (INN[1]) is a monoclonal antibody designed for the treatment of rheumatoid arthritis.[2]

This drug was being developed by Novo Nordisk A/S until Novo ceased work in inflammation.

References[edit]

  1. ^ World Health Organization (2013). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 110" (PDF). WHO Drug Information. 27 (4).
  2. ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Fletikumab, American Medical Association.